nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP3A4—Rosuvastatin—atherosclerosis	0.0603	0.211	CbGbCtD
Pilocarpine—CYP3A4—Ezetimibe—atherosclerosis	0.0603	0.211	CbGbCtD
Pilocarpine—CYP3A4—Simvastatin—atherosclerosis	0.0561	0.196	CbGbCtD
Pilocarpine—CYP3A4—Pravastatin—atherosclerosis	0.0549	0.192	CbGbCtD
Pilocarpine—CYP3A4—Lovastatin—atherosclerosis	0.0549	0.192	CbGbCtD
Pilocarpine—Urinary tract infection—Pravastatin—atherosclerosis	0.00151	0.0027	CcSEcCtD
Pilocarpine—Flushing—Ezetimibe—atherosclerosis	0.0015	0.00268	CcSEcCtD
Pilocarpine—Chills—Lovastatin—atherosclerosis	0.00148	0.00264	CcSEcCtD
Pilocarpine—Cough—Rosuvastatin—atherosclerosis	0.00148	0.00264	CcSEcCtD
Pilocarpine—Sinusitis—Pravastatin—atherosclerosis	0.00146	0.0026	CcSEcCtD
Pilocarpine—Alopecia—Lovastatin—atherosclerosis	0.00146	0.0026	CcSEcCtD
Pilocarpine—Arthralgia—Rosuvastatin—atherosclerosis	0.00144	0.00257	CcSEcCtD
Pilocarpine—Myalgia—Rosuvastatin—atherosclerosis	0.00144	0.00257	CcSEcCtD
Pilocarpine—Flushing—Simvastatin—atherosclerosis	0.00143	0.00256	CcSEcCtD
Pilocarpine—Alopecia—Ezetimibe—atherosclerosis	0.00143	0.00255	CcSEcCtD
Pilocarpine—Rhinitis—Niacin—atherosclerosis	0.00142	0.00254	CcSEcCtD
Pilocarpine—Hepatitis—Niacin—atherosclerosis	0.00141	0.00253	CcSEcCtD
Pilocarpine—Flatulence—Lovastatin—atherosclerosis	0.00141	0.00253	CcSEcCtD
Pilocarpine—Hypoaesthesia—Niacin—atherosclerosis	0.00141	0.00252	CcSEcCtD
Pilocarpine—Dysgeusia—Lovastatin—atherosclerosis	0.0014	0.00251	CcSEcCtD
Pilocarpine—Rhinitis—Pravastatin—atherosclerosis	0.0014	0.0025	CcSEcCtD
Pilocarpine—Oedema peripheral—Niacin—atherosclerosis	0.00139	0.00249	CcSEcCtD
Pilocarpine—Hepatitis—Pravastatin—atherosclerosis	0.00139	0.00249	CcSEcCtD
Pilocarpine—Confusional state—Rosuvastatin—atherosclerosis	0.00139	0.00249	CcSEcCtD
Pilocarpine—Back pain—Lovastatin—atherosclerosis	0.00139	0.00248	CcSEcCtD
Pilocarpine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00139	0.00248	CcSEcCtD
Pilocarpine—Flatulence—Ezetimibe—atherosclerosis	0.00139	0.00248	CcSEcCtD
Pilocarpine—Pharyngitis—Pravastatin—atherosclerosis	0.00138	0.00247	CcSEcCtD
Pilocarpine—Chills—Simvastatin—atherosclerosis	0.00138	0.00247	CcSEcCtD
Pilocarpine—Muscle spasms—Lovastatin—atherosclerosis	0.00138	0.00246	CcSEcCtD
Pilocarpine—Infection—Rosuvastatin—atherosclerosis	0.00137	0.00245	CcSEcCtD
Pilocarpine—Visual impairment—Niacin—atherosclerosis	0.00136	0.00244	CcSEcCtD
Pilocarpine—Alopecia—Simvastatin—atherosclerosis	0.00136	0.00243	CcSEcCtD
Pilocarpine—Back pain—Ezetimibe—atherosclerosis	0.00136	0.00243	CcSEcCtD
Pilocarpine—Muscle spasms—Ezetimibe—atherosclerosis	0.00135	0.00242	CcSEcCtD
Pilocarpine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00135	0.00242	CcSEcCtD
Pilocarpine—Vision blurred—Lovastatin—atherosclerosis	0.00135	0.00242	CcSEcCtD
Pilocarpine—Tremor—Lovastatin—atherosclerosis	0.00134	0.0024	CcSEcCtD
Pilocarpine—Visual impairment—Pravastatin—atherosclerosis	0.00134	0.0024	CcSEcCtD
Pilocarpine—Eye disorder—Niacin—atherosclerosis	0.00132	0.00236	CcSEcCtD
Pilocarpine—Flatulence—Simvastatin—atherosclerosis	0.00132	0.00236	CcSEcCtD
Pilocarpine—Tinnitus—Niacin—atherosclerosis	0.00132	0.00236	CcSEcCtD
Pilocarpine—Dysgeusia—Simvastatin—atherosclerosis	0.00131	0.00235	CcSEcCtD
Pilocarpine—Flushing—Niacin—atherosclerosis	0.00131	0.00235	CcSEcCtD
Pilocarpine—Tinnitus—Pravastatin—atherosclerosis	0.0013	0.00232	CcSEcCtD
Pilocarpine—Flushing—Pravastatin—atherosclerosis	0.00129	0.00231	CcSEcCtD
Pilocarpine—Muscle spasms—Simvastatin—atherosclerosis	0.00129	0.0023	CcSEcCtD
Pilocarpine—Leukopenia—Lovastatin—atherosclerosis	0.00128	0.00229	CcSEcCtD
Pilocarpine—Chills—Niacin—atherosclerosis	0.00127	0.00227	CcSEcCtD
Pilocarpine—Vision blurred—Simvastatin—atherosclerosis	0.00126	0.00226	CcSEcCtD
Pilocarpine—Arrhythmia—Niacin—atherosclerosis	0.00126	0.00226	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00126	0.00225	CcSEcCtD
Pilocarpine—Tremor—Simvastatin—atherosclerosis	0.00126	0.00225	CcSEcCtD
Pilocarpine—Alopecia—Niacin—atherosclerosis	0.00125	0.00223	CcSEcCtD
Pilocarpine—Chills—Pravastatin—atherosclerosis	0.00125	0.00223	CcSEcCtD
Pilocarpine—Insomnia—Rosuvastatin—atherosclerosis	0.00125	0.00223	CcSEcCtD
Pilocarpine—Arrhythmia—Pravastatin—atherosclerosis	0.00124	0.00222	CcSEcCtD
Pilocarpine—Palpitations—Ezetimibe—atherosclerosis	0.00124	0.00222	CcSEcCtD
Pilocarpine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00124	0.00222	CcSEcCtD
Pilocarpine—Alopecia—Pravastatin—atherosclerosis	0.00123	0.0022	CcSEcCtD
Pilocarpine—Cough—Ezetimibe—atherosclerosis	0.00123	0.00219	CcSEcCtD
Pilocarpine—Chest pain—Lovastatin—atherosclerosis	0.00122	0.00218	CcSEcCtD
Pilocarpine—Arthralgia—Lovastatin—atherosclerosis	0.00122	0.00218	CcSEcCtD
Pilocarpine—Myalgia—Lovastatin—atherosclerosis	0.00122	0.00218	CcSEcCtD
Pilocarpine—Anxiety—Lovastatin—atherosclerosis	0.00122	0.00217	CcSEcCtD
Pilocarpine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00122	0.00217	CcSEcCtD
Pilocarpine—Hypertension—Ezetimibe—atherosclerosis	0.00121	0.00217	CcSEcCtD
Pilocarpine—Flatulence—Niacin—atherosclerosis	0.00121	0.00217	CcSEcCtD
Pilocarpine—Tension—Niacin—atherosclerosis	0.00121	0.00216	CcSEcCtD
Pilocarpine—Discomfort—Lovastatin—atherosclerosis	0.00121	0.00216	CcSEcCtD
Pilocarpine—Leukopenia—Simvastatin—atherosclerosis	0.0012	0.00215	CcSEcCtD
Pilocarpine—Myalgia—Ezetimibe—atherosclerosis	0.0012	0.00214	CcSEcCtD
Pilocarpine—Arthralgia—Ezetimibe—atherosclerosis	0.0012	0.00214	CcSEcCtD
Pilocarpine—Chest pain—Ezetimibe—atherosclerosis	0.0012	0.00214	CcSEcCtD
Pilocarpine—Nervousness—Niacin—atherosclerosis	0.0012	0.00214	CcSEcCtD
Pilocarpine—Flatulence—Pravastatin—atherosclerosis	0.00119	0.00214	CcSEcCtD
Pilocarpine—Tension—Pravastatin—atherosclerosis	0.00119	0.00213	CcSEcCtD
Pilocarpine—Dysgeusia—Pravastatin—atherosclerosis	0.00119	0.00212	CcSEcCtD
Pilocarpine—Muscle spasms—Niacin—atherosclerosis	0.00118	0.00212	CcSEcCtD
Pilocarpine—Discomfort—Ezetimibe—atherosclerosis	0.00118	0.00211	CcSEcCtD
Pilocarpine—Pain—Rosuvastatin—atherosclerosis	0.00118	0.00211	CcSEcCtD
Pilocarpine—Constipation—Rosuvastatin—atherosclerosis	0.00118	0.00211	CcSEcCtD
Pilocarpine—Confusional state—Lovastatin—atherosclerosis	0.00118	0.00211	CcSEcCtD
Pilocarpine—Nervousness—Pravastatin—atherosclerosis	0.00118	0.00211	CcSEcCtD
Pilocarpine—Muscle spasms—Pravastatin—atherosclerosis	0.00117	0.00208	CcSEcCtD
Pilocarpine—Infection—Lovastatin—atherosclerosis	0.00116	0.00208	CcSEcCtD
Pilocarpine—Vision blurred—Niacin—atherosclerosis	0.00116	0.00207	CcSEcCtD
Pilocarpine—Confusional state—Ezetimibe—atherosclerosis	0.00116	0.00207	CcSEcCtD
Pilocarpine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00115	0.00205	CcSEcCtD
Pilocarpine—Vision blurred—Pravastatin—atherosclerosis	0.00114	0.00204	CcSEcCtD
Pilocarpine—Chest pain—Simvastatin—atherosclerosis	0.00114	0.00204	CcSEcCtD
Pilocarpine—Myalgia—Simvastatin—atherosclerosis	0.00114	0.00204	CcSEcCtD
Pilocarpine—Arthralgia—Simvastatin—atherosclerosis	0.00114	0.00204	CcSEcCtD
Pilocarpine—Infection—Ezetimibe—atherosclerosis	0.00114	0.00204	CcSEcCtD
Pilocarpine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00114	0.00203	CcSEcCtD
Pilocarpine—Anxiety—Simvastatin—atherosclerosis	0.00114	0.00203	CcSEcCtD
Pilocarpine—Tremor—Pravastatin—atherosclerosis	0.00114	0.00203	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00113	0.00202	CcSEcCtD
Pilocarpine—Discomfort—Simvastatin—atherosclerosis	0.00113	0.00202	CcSEcCtD
Pilocarpine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00112	0.00201	CcSEcCtD
Pilocarpine—Anorexia—Lovastatin—atherosclerosis	0.00112	0.00199	CcSEcCtD
Pilocarpine—Syncope—Niacin—atherosclerosis	0.0011	0.00197	CcSEcCtD
Pilocarpine—Confusional state—Simvastatin—atherosclerosis	0.0011	0.00197	CcSEcCtD
Pilocarpine—Leukopenia—Niacin—atherosclerosis	0.0011	0.00197	CcSEcCtD
Pilocarpine—Oedema—Simvastatin—atherosclerosis	0.00109	0.00196	CcSEcCtD
Pilocarpine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00109	0.00195	CcSEcCtD
Pilocarpine—Palpitations—Niacin—atherosclerosis	0.00109	0.00195	CcSEcCtD
Pilocarpine—Infection—Simvastatin—atherosclerosis	0.00109	0.00194	CcSEcCtD
Pilocarpine—Leukopenia—Pravastatin—atherosclerosis	0.00109	0.00194	CcSEcCtD
Pilocarpine—Loss of consciousness—Niacin—atherosclerosis	0.00108	0.00193	CcSEcCtD
Pilocarpine—Cough—Niacin—atherosclerosis	0.00107	0.00192	CcSEcCtD
Pilocarpine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00107	0.00192	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00107	0.00191	CcSEcCtD
Pilocarpine—Insomnia—Lovastatin—atherosclerosis	0.00106	0.00189	CcSEcCtD
Pilocarpine—Cough—Pravastatin—atherosclerosis	0.00106	0.00189	CcSEcCtD
Pilocarpine—Paraesthesia—Lovastatin—atherosclerosis	0.00105	0.00188	CcSEcCtD
Pilocarpine—Arthralgia—Niacin—atherosclerosis	0.00105	0.00187	CcSEcCtD
Pilocarpine—Myalgia—Niacin—atherosclerosis	0.00105	0.00187	CcSEcCtD
Pilocarpine—Hypertension—Pravastatin—atherosclerosis	0.00105	0.00187	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00105	0.00187	CcSEcCtD
Pilocarpine—Anorexia—Simvastatin—atherosclerosis	0.00104	0.00187	CcSEcCtD
Pilocarpine—Dyspnoea—Lovastatin—atherosclerosis	0.00104	0.00186	CcSEcCtD
Pilocarpine—Insomnia—Ezetimibe—atherosclerosis	0.00104	0.00186	CcSEcCtD
Pilocarpine—Myalgia—Pravastatin—atherosclerosis	0.00103	0.00185	CcSEcCtD
Pilocarpine—Chest pain—Pravastatin—atherosclerosis	0.00103	0.00185	CcSEcCtD
Pilocarpine—Arthralgia—Pravastatin—atherosclerosis	0.00103	0.00185	CcSEcCtD
Pilocarpine—Paraesthesia—Ezetimibe—atherosclerosis	0.00103	0.00184	CcSEcCtD
Pilocarpine—Dyspepsia—Lovastatin—atherosclerosis	0.00103	0.00184	CcSEcCtD
Pilocarpine—Anxiety—Pravastatin—atherosclerosis	0.00103	0.00184	CcSEcCtD
Pilocarpine—Dyspnoea—Ezetimibe—atherosclerosis	0.00102	0.00183	CcSEcCtD
Pilocarpine—Discomfort—Pravastatin—atherosclerosis	0.00102	0.00182	CcSEcCtD
Pilocarpine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00102	0.00182	CcSEcCtD
Pilocarpine—Decreased appetite—Lovastatin—atherosclerosis	0.00102	0.00182	CcSEcCtD
Pilocarpine—Dyspepsia—Ezetimibe—atherosclerosis	0.00101	0.00181	CcSEcCtD
Pilocarpine—Oedema—Niacin—atherosclerosis	0.001	0.0018	CcSEcCtD
Pilocarpine—Constipation—Lovastatin—atherosclerosis	0.001	0.00179	CcSEcCtD
Pilocarpine—Pain—Lovastatin—atherosclerosis	0.001	0.00179	CcSEcCtD
Pilocarpine—Confusional state—Pravastatin—atherosclerosis	0.000998	0.00178	CcSEcCtD
Pilocarpine—Decreased appetite—Ezetimibe—atherosclerosis	0.000998	0.00178	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000997	0.00178	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000991	0.00177	CcSEcCtD
Pilocarpine—Asthenia—Rosuvastatin—atherosclerosis	0.000991	0.00177	CcSEcCtD
Pilocarpine—Insomnia—Simvastatin—atherosclerosis	0.00099	0.00177	CcSEcCtD
Pilocarpine—Oedema—Pravastatin—atherosclerosis	0.000989	0.00177	CcSEcCtD
Pilocarpine—Shock—Niacin—atherosclerosis	0.000989	0.00177	CcSEcCtD
Pilocarpine—Infection—Pravastatin—atherosclerosis	0.000983	0.00176	CcSEcCtD
Pilocarpine—Paraesthesia—Simvastatin—atherosclerosis	0.000983	0.00176	CcSEcCtD
Pilocarpine—Pain—Ezetimibe—atherosclerosis	0.000981	0.00175	CcSEcCtD
Pilocarpine—Constipation—Ezetimibe—atherosclerosis	0.000981	0.00175	CcSEcCtD
Pilocarpine—Tachycardia—Niacin—atherosclerosis	0.000981	0.00175	CcSEcCtD
Pilocarpine—Pruritus—Rosuvastatin—atherosclerosis	0.000977	0.00175	CcSEcCtD
Pilocarpine—Dyspnoea—Simvastatin—atherosclerosis	0.000976	0.00174	CcSEcCtD
Pilocarpine—Hyperhidrosis—Niacin—atherosclerosis	0.000971	0.00174	CcSEcCtD
Pilocarpine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000969	0.00173	CcSEcCtD
Pilocarpine—Feeling abnormal—Lovastatin—atherosclerosis	0.000964	0.00172	CcSEcCtD
Pilocarpine—Dyspepsia—Simvastatin—atherosclerosis	0.000963	0.00172	CcSEcCtD
Pilocarpine—Anorexia—Niacin—atherosclerosis	0.000958	0.00171	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000957	0.00171	CcSEcCtD
Pilocarpine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000956	0.00171	CcSEcCtD
Pilocarpine—Decreased appetite—Simvastatin—atherosclerosis	0.000951	0.0017	CcSEcCtD
Pilocarpine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000946	0.00169	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000945	0.00169	CcSEcCtD
Pilocarpine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000945	0.00169	CcSEcCtD
Pilocarpine—Anorexia—Pravastatin—atherosclerosis	0.000943	0.00169	CcSEcCtD
Pilocarpine—Hypotension—Niacin—atherosclerosis	0.000939	0.00168	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000938	0.00168	CcSEcCtD
Pilocarpine—Pain—Simvastatin—atherosclerosis	0.000936	0.00167	CcSEcCtD
Pilocarpine—Constipation—Simvastatin—atherosclerosis	0.000936	0.00167	CcSEcCtD
Pilocarpine—Body temperature increased—Lovastatin—atherosclerosis	0.000925	0.00165	CcSEcCtD
Pilocarpine—Abdominal pain—Lovastatin—atherosclerosis	0.000925	0.00165	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000916	0.00164	CcSEcCtD
Pilocarpine—Dizziness—Rosuvastatin—atherosclerosis	0.000913	0.00163	CcSEcCtD
Pilocarpine—Insomnia—Niacin—atherosclerosis	0.000909	0.00162	CcSEcCtD
Pilocarpine—Abdominal pain—Ezetimibe—atherosclerosis	0.000907	0.00162	CcSEcCtD
Pilocarpine—Body temperature increased—Ezetimibe—atherosclerosis	0.000907	0.00162	CcSEcCtD
Pilocarpine—Paraesthesia—Niacin—atherosclerosis	0.000902	0.00161	CcSEcCtD
Pilocarpine—Feeling abnormal—Simvastatin—atherosclerosis	0.000902	0.00161	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000901	0.00161	CcSEcCtD
Pilocarpine—Dyspnoea—Niacin—atherosclerosis	0.000896	0.0016	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000895	0.0016	CcSEcCtD
Pilocarpine—Insomnia—Pravastatin—atherosclerosis	0.000895	0.0016	CcSEcCtD
Pilocarpine—Somnolence—Niacin—atherosclerosis	0.000893	0.0016	CcSEcCtD
Pilocarpine—Paraesthesia—Pravastatin—atherosclerosis	0.000888	0.00159	CcSEcCtD
Pilocarpine—Dyspepsia—Niacin—atherosclerosis	0.000885	0.00158	CcSEcCtD
Pilocarpine—Dyspnoea—Pravastatin—atherosclerosis	0.000882	0.00158	CcSEcCtD
Pilocarpine—Decreased appetite—Niacin—atherosclerosis	0.000874	0.00156	CcSEcCtD
Pilocarpine—Dyspepsia—Pravastatin—atherosclerosis	0.000871	0.00156	CcSEcCtD
Pilocarpine—Rash—Rosuvastatin—atherosclerosis	0.00087	0.00156	CcSEcCtD
Pilocarpine—Dermatitis—Rosuvastatin—atherosclerosis	0.00087	0.00155	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000868	0.00155	CcSEcCtD
Pilocarpine—Body temperature increased—Simvastatin—atherosclerosis	0.000865	0.00155	CcSEcCtD
Pilocarpine—Abdominal pain—Simvastatin—atherosclerosis	0.000865	0.00155	CcSEcCtD
Pilocarpine—Headache—Rosuvastatin—atherosclerosis	0.000865	0.00155	CcSEcCtD
Pilocarpine—Hypersensitivity—Lovastatin—atherosclerosis	0.000862	0.00154	CcSEcCtD
Pilocarpine—Decreased appetite—Pravastatin—atherosclerosis	0.00086	0.00154	CcSEcCtD
Pilocarpine—Pain—Niacin—atherosclerosis	0.000859	0.00154	CcSEcCtD
Pilocarpine—Pain—Pravastatin—atherosclerosis	0.000846	0.00151	CcSEcCtD
Pilocarpine—Constipation—Pravastatin—atherosclerosis	0.000846	0.00151	CcSEcCtD
Pilocarpine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000845	0.00151	CcSEcCtD
Pilocarpine—Asthenia—Lovastatin—atherosclerosis	0.000839	0.0015	CcSEcCtD
Pilocarpine—Pruritus—Lovastatin—atherosclerosis	0.000828	0.00148	CcSEcCtD
Pilocarpine—Asthenia—Ezetimibe—atherosclerosis	0.000823	0.00147	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Niacin—atherosclerosis	0.000822	0.00147	CcSEcCtD
Pilocarpine—Nausea—Rosuvastatin—atherosclerosis	0.00082	0.00147	CcSEcCtD
Pilocarpine—Feeling abnormal—Pravastatin—atherosclerosis	0.000815	0.00146	CcSEcCtD
Pilocarpine—Pruritus—Ezetimibe—atherosclerosis	0.000812	0.00145	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000809	0.00145	CcSEcCtD
Pilocarpine—Hypersensitivity—Simvastatin—atherosclerosis	0.000806	0.00144	CcSEcCtD
Pilocarpine—Diarrhoea—Lovastatin—atherosclerosis	0.000801	0.00143	CcSEcCtD
Pilocarpine—Abdominal pain—Niacin—atherosclerosis	0.000794	0.00142	CcSEcCtD
Pilocarpine—Body temperature increased—Niacin—atherosclerosis	0.000794	0.00142	CcSEcCtD
Pilocarpine—Asthenia—Simvastatin—atherosclerosis	0.000785	0.0014	CcSEcCtD
Pilocarpine—Diarrhoea—Ezetimibe—atherosclerosis	0.000785	0.0014	CcSEcCtD
Pilocarpine—Abdominal pain—Pravastatin—atherosclerosis	0.000782	0.0014	CcSEcCtD
Pilocarpine—Body temperature increased—Pravastatin—atherosclerosis	0.000782	0.0014	CcSEcCtD
Pilocarpine—Pruritus—Simvastatin—atherosclerosis	0.000774	0.00138	CcSEcCtD
Pilocarpine—Dizziness—Lovastatin—atherosclerosis	0.000774	0.00138	CcSEcCtD
Pilocarpine—Dizziness—Ezetimibe—atherosclerosis	0.000759	0.00136	CcSEcCtD
Pilocarpine—Diarrhoea—Simvastatin—atherosclerosis	0.000749	0.00134	CcSEcCtD
Pilocarpine—Vomiting—Lovastatin—atherosclerosis	0.000744	0.00133	CcSEcCtD
Pilocarpine—Hypersensitivity—Niacin—atherosclerosis	0.00074	0.00132	CcSEcCtD
Pilocarpine—Rash—Lovastatin—atherosclerosis	0.000738	0.00132	CcSEcCtD
Pilocarpine—Dermatitis—Lovastatin—atherosclerosis	0.000737	0.00132	CcSEcCtD
Pilocarpine—Headache—Lovastatin—atherosclerosis	0.000733	0.00131	CcSEcCtD
Pilocarpine—Vomiting—Ezetimibe—atherosclerosis	0.00073	0.0013	CcSEcCtD
Pilocarpine—Hypersensitivity—Pravastatin—atherosclerosis	0.000729	0.0013	CcSEcCtD
Pilocarpine—Dizziness—Simvastatin—atherosclerosis	0.000724	0.00129	CcSEcCtD
Pilocarpine—Rash—Ezetimibe—atherosclerosis	0.000724	0.00129	CcSEcCtD
Pilocarpine—Dermatitis—Ezetimibe—atherosclerosis	0.000723	0.00129	CcSEcCtD
Pilocarpine—Asthenia—Niacin—atherosclerosis	0.000721	0.00129	CcSEcCtD
Pilocarpine—Headache—Ezetimibe—atherosclerosis	0.000719	0.00129	CcSEcCtD
Pilocarpine—Pruritus—Niacin—atherosclerosis	0.000711	0.00127	CcSEcCtD
Pilocarpine—Asthenia—Pravastatin—atherosclerosis	0.00071	0.00127	CcSEcCtD
Pilocarpine—Pruritus—Pravastatin—atherosclerosis	0.0007	0.00125	CcSEcCtD
Pilocarpine—Vomiting—Simvastatin—atherosclerosis	0.000696	0.00124	CcSEcCtD
Pilocarpine—Nausea—Lovastatin—atherosclerosis	0.000695	0.00124	CcSEcCtD
Pilocarpine—Rash—Simvastatin—atherosclerosis	0.00069	0.00123	CcSEcCtD
Pilocarpine—Dermatitis—Simvastatin—atherosclerosis	0.000689	0.00123	CcSEcCtD
Pilocarpine—Diarrhoea—Niacin—atherosclerosis	0.000688	0.00123	CcSEcCtD
Pilocarpine—Headache—Simvastatin—atherosclerosis	0.000686	0.00123	CcSEcCtD
Pilocarpine—Nausea—Ezetimibe—atherosclerosis	0.000682	0.00122	CcSEcCtD
Pilocarpine—Diarrhoea—Pravastatin—atherosclerosis	0.000677	0.00121	CcSEcCtD
Pilocarpine—Dizziness—Niacin—atherosclerosis	0.000664	0.00119	CcSEcCtD
Pilocarpine—Dizziness—Pravastatin—atherosclerosis	0.000654	0.00117	CcSEcCtD
Pilocarpine—Nausea—Simvastatin—atherosclerosis	0.00065	0.00116	CcSEcCtD
Pilocarpine—Vomiting—Niacin—atherosclerosis	0.000639	0.00114	CcSEcCtD
Pilocarpine—Rash—Niacin—atherosclerosis	0.000634	0.00113	CcSEcCtD
Pilocarpine—Dermatitis—Niacin—atherosclerosis	0.000633	0.00113	CcSEcCtD
Pilocarpine—Headache—Niacin—atherosclerosis	0.00063	0.00113	CcSEcCtD
Pilocarpine—Vomiting—Pravastatin—atherosclerosis	0.000629	0.00112	CcSEcCtD
Pilocarpine—Rash—Pravastatin—atherosclerosis	0.000624	0.00112	CcSEcCtD
Pilocarpine—Dermatitis—Pravastatin—atherosclerosis	0.000623	0.00111	CcSEcCtD
Pilocarpine—Headache—Pravastatin—atherosclerosis	0.00062	0.00111	CcSEcCtD
Pilocarpine—Nausea—Niacin—atherosclerosis	0.000597	0.00107	CcSEcCtD
Pilocarpine—Nausea—Pravastatin—atherosclerosis	0.000588	0.00105	CcSEcCtD
Pilocarpine—CHRM2—Signaling Pathways—CCR2—atherosclerosis	4.61e-05	0.000299	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	4.61e-05	0.000299	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	4.59e-05	0.000298	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CYBA—atherosclerosis	4.59e-05	0.000298	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PLAT—atherosclerosis	4.55e-05	0.000295	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GHRL—atherosclerosis	4.55e-05	0.000295	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PARP1—atherosclerosis	4.55e-05	0.000295	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	4.55e-05	0.000295	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—HMOX1—atherosclerosis	4.54e-05	0.000295	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GHRL—atherosclerosis	4.54e-05	0.000294	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PLAT—atherosclerosis	4.54e-05	0.000294	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PARP1—atherosclerosis	4.54e-05	0.000294	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	4.49e-05	0.000291	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	4.49e-05	0.000291	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	4.49e-05	0.000291	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—F2—atherosclerosis	4.37e-05	0.000284	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—F2—atherosclerosis	4.36e-05	0.000283	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—APOB—atherosclerosis	4.35e-05	0.000282	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—F2—atherosclerosis	4.32e-05	0.00028	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—HMOX1—atherosclerosis	4.26e-05	0.000276	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTM1—atherosclerosis	4.23e-05	0.000274	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	4.18e-05	0.000271	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ABCA1—atherosclerosis	4.18e-05	0.000271	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	4.17e-05	0.000271	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—LPL—atherosclerosis	4.15e-05	0.000269	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.14e-05	0.000269	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	4.13e-05	0.000268	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—APOB—atherosclerosis	4.08e-05	0.000265	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GPX1—atherosclerosis	4.05e-05	0.000263	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	4e-05	0.000259	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KNG1—atherosclerosis	3.98e-05	0.000258	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	3.97e-05	0.000258	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTM1—atherosclerosis	3.97e-05	0.000257	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	3.96e-05	0.000257	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CD36—atherosclerosis	3.95e-05	0.000256	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	3.94e-05	0.000256	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	3.92e-05	0.000254	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	3.9e-05	0.000253	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—FABP4—atherosclerosis	3.9e-05	0.000253	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LCAT—atherosclerosis	3.9e-05	0.000253	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—LPL—atherosclerosis	3.89e-05	0.000253	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	3.88e-05	0.000252	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PLG—atherosclerosis	3.87e-05	0.000251	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PLG—atherosclerosis	3.86e-05	0.00025	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	3.85e-05	0.00025	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOA4—atherosclerosis	3.82e-05	0.000248	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PLG—atherosclerosis	3.82e-05	0.000248	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GPX1—atherosclerosis	3.8e-05	0.000246	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.76e-05	0.000244	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—MTHFR—atherosclerosis	3.74e-05	0.000243	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CD36—atherosclerosis	3.7e-05	0.00024	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PPARA—atherosclerosis	3.67e-05	0.000238	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	3.67e-05	0.000238	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	3.65e-05	0.000237	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	3.62e-05	0.000235	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HMOX1—atherosclerosis	3.59e-05	0.000233	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AGT—atherosclerosis	3.55e-05	0.00023	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	3.54e-05	0.00023	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP3—atherosclerosis	3.53e-05	0.000229	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	3.52e-05	0.000229	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IGF2—atherosclerosis	3.51e-05	0.000228	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—MTHFR—atherosclerosis	3.51e-05	0.000227	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	3.49e-05	0.000227	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—APOE—atherosclerosis	3.48e-05	0.000226	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	3.48e-05	0.000226	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.47e-05	0.000225	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CAV1—atherosclerosis	3.45e-05	0.000224	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—APOA1—atherosclerosis	3.44e-05	0.000223	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PPARA—atherosclerosis	3.44e-05	0.000223	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—APOB—atherosclerosis	3.44e-05	0.000223	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APOB—atherosclerosis	3.42e-05	0.000222	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APOB—atherosclerosis	3.41e-05	0.000221	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	3.39e-05	0.00022	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	3.38e-05	0.000219	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APOB—atherosclerosis	3.38e-05	0.000219	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	3.37e-05	0.000218	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EDN1—atherosclerosis	3.36e-05	0.000218	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	3.35e-05	0.000217	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTM1—atherosclerosis	3.34e-05	0.000217	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	3.34e-05	0.000217	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AGT—atherosclerosis	3.33e-05	0.000216	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCL5—atherosclerosis	3.33e-05	0.000216	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	3.32e-05	0.000216	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	3.3e-05	0.000214	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOA2—atherosclerosis	3.29e-05	0.000214	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.29e-05	0.000214	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.29e-05	0.000214	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.29e-05	0.000214	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—LPL—atherosclerosis	3.28e-05	0.000213	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—LPL—atherosclerosis	3.27e-05	0.000212	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—APOE—atherosclerosis	3.26e-05	0.000212	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—LPL—atherosclerosis	3.26e-05	0.000211	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.25e-05	0.000211	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CAV1—atherosclerosis	3.23e-05	0.00021	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—APOA1—atherosclerosis	3.23e-05	0.000209	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—LPL—atherosclerosis	3.22e-05	0.000209	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GPX1—atherosclerosis	3.2e-05	0.000208	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	3.18e-05	0.000206	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	3.17e-05	0.000205	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CG—atherosclerosis	3.14e-05	0.000204	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LPA—atherosclerosis	3.14e-05	0.000204	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	3.14e-05	0.000203	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CD36—atherosclerosis	3.12e-05	0.000202	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	3.09e-05	0.000201	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SPP1—atherosclerosis	3.08e-05	0.0002	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	3.08e-05	0.0002	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	3.07e-05	0.000199	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	3.05e-05	0.000198	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—BGN—atherosclerosis	3.04e-05	0.000197	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	3.04e-05	0.000197	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PPARG—atherosclerosis	3.03e-05	0.000197	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOA5—atherosclerosis	3.01e-05	0.000195	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—INS—atherosclerosis	2.97e-05	0.000193	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—MTHFR—atherosclerosis	2.95e-05	0.000192	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CG—atherosclerosis	2.95e-05	0.000191	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARA—atherosclerosis	2.9e-05	0.000188	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.9e-05	0.000188	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	2.86e-05	0.000186	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	2.85e-05	0.000185	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PPARG—atherosclerosis	2.84e-05	0.000184	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	2.83e-05	0.000183	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AGT—atherosclerosis	2.81e-05	0.000182	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.8e-05	0.000182	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AGT—atherosclerosis	2.79e-05	0.000181	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—INS—atherosclerosis	2.79e-05	0.000181	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AGT—atherosclerosis	2.79e-05	0.000181	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AGT—atherosclerosis	2.76e-05	0.000179	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—APOE—atherosclerosis	2.75e-05	0.000178	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APOE—atherosclerosis	2.74e-05	0.000178	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—LEP—atherosclerosis	2.74e-05	0.000178	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—LEP—atherosclerosis	2.73e-05	0.000177	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APOE—atherosclerosis	2.73e-05	0.000177	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALB—atherosclerosis	2.73e-05	0.000177	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CAV1—atherosclerosis	2.73e-05	0.000177	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—APOA1—atherosclerosis	2.72e-05	0.000176	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	2.71e-05	0.000176	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	2.71e-05	0.000176	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CAV1—atherosclerosis	2.7e-05	0.000175	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—LEP—atherosclerosis	2.7e-05	0.000175	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APOE—atherosclerosis	2.7e-05	0.000175	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APOA1—atherosclerosis	2.7e-05	0.000175	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	2.68e-05	0.000174	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	2.67e-05	0.000173	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	2.61e-05	0.00017	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NOS3—atherosclerosis	2.61e-05	0.000169	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ESR1—atherosclerosis	2.61e-05	0.000169	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—F2—atherosclerosis	2.58e-05	0.000168	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	2.58e-05	0.000167	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—F2—atherosclerosis	2.57e-05	0.000167	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALB—atherosclerosis	2.56e-05	0.000166	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—F2—atherosclerosis	2.55e-05	0.000165	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.51e-05	0.000163	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LIPC—atherosclerosis	2.49e-05	0.000162	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	2.48e-05	0.000161	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOC3—atherosclerosis	2.48e-05	0.000161	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	2.47e-05	0.00016	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LDLR—atherosclerosis	2.46e-05	0.00016	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	2.46e-05	0.00016	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NOS3—atherosclerosis	2.45e-05	0.000159	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	2.44e-05	0.000158	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CETP—atherosclerosis	2.41e-05	0.000156	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARG—atherosclerosis	2.4e-05	0.000155	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS2—atherosclerosis	2.38e-05	0.000155	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	2.37e-05	0.000154	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	2.36e-05	0.000153	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—INS—atherosclerosis	2.35e-05	0.000152	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—INS—atherosclerosis	2.34e-05	0.000152	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	2.34e-05	0.000152	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—INS—atherosclerosis	2.33e-05	0.000151	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—INS—atherosclerosis	2.31e-05	0.00015	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.31e-05	0.00015	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	2.3e-05	0.000149	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCL2—atherosclerosis	2.29e-05	0.000149	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	2.27e-05	0.000147	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	2.26e-05	0.000147	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IGF1—atherosclerosis	2.26e-05	0.000146	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS2—atherosclerosis	2.24e-05	0.000145	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	2.23e-05	0.000145	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.18e-05	0.000141	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALB—atherosclerosis	2.15e-05	0.00014	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	2.15e-05	0.000139	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	2.14e-05	0.000139	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	2.12e-05	0.000138	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NOS3—atherosclerosis	2.06e-05	0.000134	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	2.05e-05	0.000133	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	2.04e-05	0.000133	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	2.03e-05	0.000131	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.94e-05	0.000126	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.88e-05	0.000122	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	1.82e-05	0.000118	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	1.81e-05	0.000118	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	1.8e-05	0.000117	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.76e-05	0.000114	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	1.75e-05	0.000114	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	1.74e-05	0.000113	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	1.73e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	1.72e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	1.71e-05	0.000111	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.66e-05	0.000108	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	1.65e-05	0.000107	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	1.64e-05	0.000106	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	1.63e-05	0.000106	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	1.62e-05	0.000105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	1.62e-05	0.000105	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	1.61e-05	0.000104	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	1.6e-05	0.000104	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	1.6e-05	0.000104	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	1.6e-05	0.000104	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOB—atherosclerosis	1.59e-05	0.000103	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	1.59e-05	0.000103	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	1.58e-05	0.000103	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	1.58e-05	0.000102	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.55e-05	0.000101	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LPL—atherosclerosis	1.52e-05	9.88e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GPX1—atherosclerosis	1.49e-05	9.64e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.48e-05	9.59e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.47e-05	9.56e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.46e-05	9.49e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.46e-05	9.46e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.46e-05	9.46e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CD36—atherosclerosis	1.45e-05	9.38e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.44e-05	9.37e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.4e-05	9.07e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.39e-05	9.04e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.38e-05	8.95e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.37e-05	8.89e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.36e-05	8.8e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.35e-05	8.77e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.34e-05	8.72e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.34e-05	8.69e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AGT—atherosclerosis	1.3e-05	8.45e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOE—atherosclerosis	1.28e-05	8.28e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.26e-05	8.2e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.26e-05	8.18e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKT1—atherosclerosis	1.2e-05	7.78e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.15e-05	7.47e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKT1—atherosclerosis	1.12e-05	7.29e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.11e-05	7.21e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—INS—atherosclerosis	1.09e-05	7.07e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.02e-05	6.63e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.02e-05	6.61e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.01e-05	6.55e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALB—atherosclerosis	9.99e-06	6.48e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NOS3—atherosclerosis	9.56e-06	6.2e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKT1—atherosclerosis	9.47e-06	6.15e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	9.43e-06	6.12e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	9.4e-06	6.1e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	9.31e-06	6.04e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS2—atherosclerosis	8.74e-06	5.67e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKT1—atherosclerosis	4.39e-06	2.85e-05	CbGpPWpGaD
